Patients with HER2-positive cancers can have dramatic responses to HER2-targeted drugs but eventually develop resistance to the agents. With that problem in mind, researchers are testing a novel type of antibody called MM-111 in patients with HER2-positive disease who have progressed on standard therapy.
Results 1 to 1 of 1
MEDiscuss • Medical News • New cancer treatment? MM-111 antibody uses HER2 target to reach and block HER3
- June 5th, 2010 #1Bot
- Member since
- Jul 2007
- Posts
- 20,745
New cancer treatment? MM-111 antibody uses HER2 target to reach and block HER3
QuoteRelated Posts
-
Researchers identify a signaling pathway as possible target for cancer treatment
By MedBot in forum Medical NewsReplies: 0Last Post: August 15th, 2011, 06:07 PM -
Transcription factor is potential target for liver cancer treatment
By MedBot in forum Medical NewsReplies: 0Last Post: July 6th, 2011, 05:00 PM -
Scientists find way to block stress-related cell death: New drug target for heart attack, stroke and Parkinson's disease?
By MedBot in forum Medical NewsReplies: 0Last Post: June 2nd, 2011, 08:07 PM -
A potential novel drug-target for colorectal cancer treatment comes from the brain
By MedBot in forum Medical NewsReplies: 0Last Post: April 26th, 2011, 07:02 PM -
New target for treatment of advanced prostate cancer
By MedBot in forum Medical NewsReplies: 0Last Post: July 7th, 2010, 03:13 AM
Posting Permissions
The information provided on this site is meant to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician
© 2007 - 2012 MEDiscuss | Powered by vBulletin® | Search Engine Optimization by vBSEO | vB skin by CompleteVB
© 2007 - 2012 MEDiscuss | Powered by vBulletin® | Search Engine Optimization by vBSEO | vB skin by CompleteVB
All times are GMT. The time now is 05:31 PM.